Results 111 to 120 of about 2,906 (160)

Longitudinal Assessment of 4-Year HFMSE Changes in SMA II and III Patients Treated With Nusinersen. [PDF]

Eur J Neurol
Coratti G, Bovis F, Pane M, Pasternak A, Albamonte E, Mizzoni I, Glanzman AM, Morando S, Montes J, Cavallina I, Dunaway Young S, Duong T, Rolle E, Civitello M, De Sanctis R, Bravetti C, Ricci F, Gadaleta G, Mongini T, Sframeli M, Pera MC, Messina S, D'Amico A, Catteruccia M, Brolatti N, Hirano M, Zolkipli-Cunningham Z, Darras BT, Bertini E, Bruno C, Day J, Sansone VA, Finkel RS, Mercuri E, iSMAC/international SMA consortium.   +34 more
europepmc   +1 more source

Rehabilitation improves the effectiveness of nusinersen in children with type 2 spinal muscular atrophy: pNF-H and muscle MRI as potential biomarkers. [PDF]

Front Neurol
Sun Y, Li W, Cui X, Li Y, Gao X, Fu D, Zhao X, Cao T, Zhu M.   +8 more
europepmc   +1 more source

Cost comparison analysis of onasemnogene abeparvovec and nusinersen for treatment of patients with spinal muscular atrophy type 1 in the Netherlands. [PDF]

Eur J Health Econ
van der Schans S, Velikanova R, Weidlich D, Howells R, Patel A, Bischof M, Postma MJ, Boersma C.   +7 more
europepmc   +1 more source

Total Intramuscular Fat Fraction of Thigh Muscles as a Predictor of Nusinersen Efficacy in Pediatric SMA Type II and III. [PDF]

Diagnostics (Basel)
Iketani K, Awano H, Hashimura H, Sonehara S, Hanafusa H, Nambu Y, Nishio H, Nozu K, Bo R.   +8 more
europepmc   +1 more source

Long-term CSF responses in adult patients with spinal muscular atrophy type 2 or 3 on treatment with nusinersen. [PDF]

J Neurol
Cebulla G, Hai L, Warnken U, Güngör C, Hoffmann DC, Korporal-Kuhnke M, Wildemann B, Wick W, Kessler T, Weiler M.   +9 more
europepmc   +1 more source

The long-term efficacy of nusinersen on respiratory functions in children with symptomatic spinal muscular atrophy type 1. [PDF]

Turk J Med Sci
Kiliç MA, Kürekçi F, Kipoğlu O, Coşkun O, Karacebey BN, Katar S, Avci R, Genç HM, Çakir E, Yildiz EP.   +9 more
europepmc   +1 more source

Serum creatinine to cystatin C ratio as monitoring biomarker in Chinese adult spinal muscular atrophy: a prospective cohort study. [PDF]

Orphanet J Rare Dis
Chen S, Wang Q, Fu J, Wei Q, Ou R, Lai X, Chen X, Shang H.   +7 more
europepmc   +1 more source

Scoliosis in spinal muscular atrophy in the era of disease-modifying therapy: a scoping review. [PDF]

Neurol Sci
Gnazzo M, Pisanò G, Piccolo B, Turco EC, Esposito S, Pera MC.   +5 more
europepmc   +1 more source

The effect of thoracolumbosacral orthosis on scoliosis progression and chest deformity in children with type 1 spinal muscular atrophy: A randomized controlled trial. [PDF]

PLoS One
Dansuk E, Van Den Berg ANT, Ata G, Yıkılmaz SK, Oktem S.   +4 more
europepmc   +1 more source